Task: Answer the multiple-choice question.
Question: Which drug exhibits a 8.595% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a Cc1cc(NC(=O)C2CCCCC2)ncc1NC(=O)c1ccccn1
b Cc1[nH]nc2c1/C(=N/O)CC(c1ccccc1)C2
c CCOC(=O)c1c(S(=O)(=O)NCC(=O)Nc2cc(C)ccn2)c(C)n(C)c1C
Answer: a. Cc1cc(NC(=O)C2CCCCC2)ncc1NC(=O)c1ccccn1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc(NC(=O)C2CCCCC2)ncc1NC(=O)c1ccccn1
Cc1cc(NC(=O)C2CCCCC2)ncc1NC(=O)c1ccccn1
N-[6-(cyclohexanecarbonylamino)-4-methylpyridin-3-yl]pyridine-2-carboxamide